Target Healthcare REIT (LON:THRL – Get Free Report)‘s stock had its “hold” rating reiterated by equities research analysts at Jefferies Financial Group in a report released on Wednesday,London Stock Exchange reports. They presently have a GBX 101 price target on the stock. Jefferies Financial Group’s price objective suggests a potential downside of 10.30% from the company’s current price.
Target Healthcare REIT Price Performance
THRL stock traded down GBX 1.20 during trading hours on Wednesday, reaching GBX 112.60. 745,235 shares of the stock were exchanged, compared to its average volume of 5,744,188. The firm’s 50-day moving average is GBX 109.66 and its 200-day moving average is GBX 106.21. The company has a market cap of £698.39 million, a price-to-earnings ratio of 8.96, a PEG ratio of 1.48 and a beta of 0.71. Target Healthcare REIT has a 12 month low of GBX 92 and a 12 month high of GBX 117.
Target Healthcare REIT Company Profile
Recommended Stories
- Five stocks we like better than Target Healthcare REIT
- The FTC Is Suing Hims & Hers Health—Here’s Why Investors Shouldn’t Panic
- 3 Stocks Taking Very Different Routes Through the Summer Rally
- Is ADM’s Rally Getting Ahead of Its Policy Tailwind?
- CoreWeave Powers Up: The Asia Infrastructure Grab
Receive News & Ratings for Target Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Target Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
